These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23341763)

  • 1. Effects of ligand binding on the mechanical properties of ankyrin repeat protein gankyrin.
    Settanni G; Serquera D; Marszalek PE; Paci E; Itzhaki LS
    PLoS Comput Biol; 2013; 9(1):e1002864. PubMed ID: 23341763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic Proteins Potently and Selectively Bind the Oncoprotein Gankyrin, Modulate Its Interaction with S6 ATPase, and Suppress Gankyrin/MDM2-Dependent Ubiquitination of p53.
    Chapman AM; McNaughton BR
    ACS Chem Biol; 2015 Aug; 10(8):1880-6. PubMed ID: 25955581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanical unfolding of an ankyrin repeat protein.
    Serquera D; Lee W; Settanni G; Marszalek PE; Paci E; Itzhaki LS
    Biophys J; 2010 Apr; 98(7):1294-301. PubMed ID: 20371329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the oncoprotein gankyrin in complex with S6 ATPase of the 26S proteasome.
    Nakamura Y; Nakano K; Umehara T; Kimura M; Hayashizaki Y; Tanaka A; Horikoshi M; Padmanabhan B; Yokoyama S
    Structure; 2007 Feb; 15(2):179-89. PubMed ID: 17292836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53.
    Higashitsuji H; Higashitsuji H; Itoh K; Sakurai T; Nagao T; Sumitomo Y; Masuda T; Dawson S; Shimada Y; Mayer RJ; Fujita J
    Cancer Cell; 2005 Jul; 8(1):75-87. PubMed ID: 16023600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The oncoprotein gankyrin negatively regulates both p53 and RB by enhancing proteasomal degradation.
    Higashitsuji H; Liu Y; Mayer RJ; Fujita J
    Cell Cycle; 2005 Oct; 4(10):1335-7. PubMed ID: 16177571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resurfaced shape complementary proteins that selectively bind the oncoprotein gankyrin.
    Chapman AM; McNaughton BR
    ACS Chem Biol; 2014 Oct; 9(10):2223-8. PubMed ID: 25137482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gankyrin is an ankyrin-repeat oncoprotein that interacts with CDK4 kinase and the S6 ATPase of the 26 S proteasome.
    Dawson S; Apcher S; Mee M; Higashitsuji H; Baker R; Uhle S; Dubiel W; Fujita J; Mayer RJ
    J Biol Chem; 2002 Mar; 277(13):10893-902. PubMed ID: 11779854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of a small-molecule binder of the oncoprotein gankyrin that modulates gankyrin activity in the cell.
    Chattopadhyay A; O'Connor CJ; Zhang F; Galvagnion C; Galloway WR; Tan YS; Stokes JE; Rahman T; Verma C; Spring DR; Itzhaki LS
    Sci Rep; 2016 Apr; 6():23732. PubMed ID: 27046077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissection of protein-protein interaction and CDK4 inhibition in the oncogenic versus tumor suppressing functions of gankyrin and P16.
    Mahajan A; Guo Y; Yuan C; Weghorst CM; Tsai MD; Li J
    J Mol Biol; 2007 Nov; 373(4):990-1005. PubMed ID: 17881001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solution structure of the human oncogenic protein gankyrin containing seven ankyrin repeats and analysis of its structure--function relationship.
    Yuan C; Li J; Mahajan A; Poi MJ; Byeon IJ; Tsai MD
    Biochemistry; 2004 Sep; 43(38):12152-61. PubMed ID: 15379554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The crystal structure of gankyrin, an oncoprotein found in complexes with cyclin-dependent kinase 4, a 19 S proteasomal ATPase regulator, and the tumor suppressors Rb and p53.
    Krzywda S; Brzozowski AM; Higashitsuji H; Fujita J; Welchman R; Dawson S; Mayer RJ; Wilkinson AJ
    J Biol Chem; 2004 Jan; 279(2):1541-5. PubMed ID: 14573599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of multiple interacting partners of gankyrin, a proteasomal chaperone and an oncoprotein--evidence for a common hot spot site at the interface and its functional relevance.
    Nanaware PP; Ramteke MP; Somavarapu AK; Venkatraman P
    Proteins; 2014 Jul; 82(7):1283-300. PubMed ID: 24338975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovering a potent small molecule inhibitor for gankyrin using de novo drug design approach.
    Thakur PK; Hassan I
    Int J Comput Biol Drug Des; 2011; 4(4):373-86. PubMed ID: 22199037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The study of pH-dependent stability shows that the TPLH-mediated hydrogen-bonding network is important for the conformation and stability of human gankyrin.
    Yuan C; Guo Y; Zhu L; Guo W; Mahajan A; Weghorst CM; Li J
    Biochemistry; 2013 Jul; 52(28):4848-57. PubMed ID: 23777370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The oncoprotein gankyrin interacts with RelA and suppresses NF-kappaB activity.
    Higashitsuji H; Higashitsuji H; Liu Y; Masuda T; Fujita T; Abdel-Aziz HI; Kongkham S; Dawson S; John Mayer R; Itoh Y; Sakurai T; Itoh K; Fujita J
    Biochem Biophys Res Commun; 2007 Nov; 363(3):879-84. PubMed ID: 17904523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing the aryl-triazole of cjoc42 for enhanced gankyrin binding and anti-cancer activity.
    Kanabar D; Farrales P; Kabir A; Juang D; Gnanmony M; Almasri J; Torrents N; Shukla S; Gupta V; Dukhande VV; D'Souza A; Muth A
    Bioorg Med Chem Lett; 2020 Sep; 30(17):127372. PubMed ID: 32738965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of the homolog of the oncoprotein gankyrin, an interactor of Rb and CDK4/6.
    Padmanabhan B; Adachi N; Kataoka K; Horikoshi M
    J Biol Chem; 2004 Jan; 279(2):1546-52. PubMed ID: 14583612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of human oncoprotein gankyrin in Zebrafish.
    Kim SY; Hur W; Choi JE; Kim D; Wang JS; Yoon HY; Piao LS; Yoon SK
    Exp Mol Med; 2009 Jan; 41(1):8-16. PubMed ID: 19287195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel insights into the INK4-CDK4/6-Rb pathway: counter action of gankyrin against INK4 proteins regulates the CDK4-mediated phosphorylation of Rb.
    Li J; Tsai MD
    Biochemistry; 2002 Mar; 41(12):3977-83. PubMed ID: 11900540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.